O N a population level, most cognitive abilities such as memory function, information processing speed, and attentional capacity tend to decline with advancing age (1, 2) . It is clear that the preservation of cognitive abilities is of primary importance to older people, as cognitive decline in the aged can result in a loss of independence and autonomy (3). Interindividual differences, however, exist in the rate of decline of specific cognitive functions that can, at least in part, be mediated by individual differences in physical health (4, 5) . Several studies have suggested that healthrelated factors, such as closed head injuries, general anesthesia, and chronic psychotropic medication use (6, 7) , may be involved in the enhanced cognitive decline seen with increasing age. In addition, several disease entities have been associated with a reduced cognitive capacity in epidemiological surveys and clinical case-control studies (8) . For example, disorders such as thyroid disease, renal or hepatic failure, cardiac insufficiency, or chronic obstructive pulmonary disease may be accompanied by relatively nonspecific neuropsychological deficits (9) and may aggravate a dementia syndrome in geriatric populations (10) .
Mild cognitive impairment with no frank dementia (CIND) has recently been recognized as a relevant clinical entity that must be identified in an early stage of its development (11) . The family physician may play a crucial role in recognizing patients who are at risk of cognitive deterioration that is mediated by physical disease or disability, as he or she is pre-eminently confronted with early stages of disease. It is unclear, however, if the findings on cognitionrelated morbidity in clinical populations can be readily transposed to general practice. Clinical studies most often refer to advanced stages of disease and are thus biased to overestimate the potential effect of specific morbidity on cognitive function in earlier stages. A cross-sectional design was used to ascertain the potential relevance of well-described morbidity categories as mediators of cognitive function in a large sample of community living adult individuals, using established classification criteria for existing morbidity in general practice.
METHODS

Sample Frame
This study was part of a larger research program on determinants of normal cognitive aging, the Maastricht Aging Study (MAAS; ref. 12) . Participants were recruited from the Registration Network Family Practices (RNH; ref. 13 ). The Registration Network was established primarily as a sampling frame for research purposes. It consists of the background characteristics and health problems of patients in 15 general practices that are updated on a continuous basis via a computerized system. Health problems are classified according to the International Classification of Primary Care (ICPC; ref. 14) , together with the dates of becoming active and, for some problems, of becoming inactive. A health problem is acknowledged as such when it Ml 48
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affects the functional status of the individual at present or in the future. Therefore, as a rule, only permanent, chronic, or recurrent problems are included (13) .
The a priori knowledge on the medical status of Registration Network patients enabled exclusion of individuals with evidence of stroke, chronic neurological pathology (e.g., dementia, epilepsy, parkinsonism, and malignancies related to the nervous system), mental retardation, or chronic psychotropic drug use: 4.0% of the patients in the register who were eligible with respect to age criteria were thus omitted from the sampling procedure. Participants were stratified for age (12 age classes, ranging from 25 ± 1 year, 30 ± 1 year, to 80 ± 1 year), sex, and level of general ability (two levels, based on the achievement in professional life; ref. 15) , to control these background variables that in itself may affect cognitive performance (12) . The study populations of the first three MAAS panel studies, executed between April 1993 and December 1995, were combined in this study. Of the 8340 patients who were drawn from the register to accommodate these panel studies (including a large postal survey into memory and memory-related function in the first panel study, which is not discussed here) and who were invited directly by their general practitioner, 3741 patients basically agreed to participate (44.9%). From this group, a sample of 1905 patients was actually contacted by the researchers by telephone. They were screened for the current use of psychotropic medication and extremely poor visual or auditory function incompatible with cognitive testing. This resulted in exclusion of 11.7% of the patients. In addition, 16.3% withdrew before or after more in-depth information about the test program had been given. Of the resulting 1373 patients who actually took part in the test program, 13 were not included in the present analysis due to one or more missing values in the cognitive data set. Participating and nonparticipating groups did not differ with respect to the number of medical problems or the presence of chronic diseases, as recorded by their general practitioners. Noncomplying subjects in the first step of recruitment were found more often in the youngest or oldest age classes, were less well educated, and were more often female (12) .
Measurements
All participants filled in a questionnaire pertaining to socioeconomic background and medical history. Educational level was measured on an 8-point scale, ranging from primary school to higher vocational training and university degree (12) .
Cognitive Assessment
Standard neuropsychological tests were used to assess the cognitive domains of memory, sensorimotor speed and information processing speed/cognitive flexibility (16) .
The Word Learning Task (WLT) evaluates the ability to acquire and retain new verbal information (17) . A set of 15 frequently used monosyllabic words is presented in fixed order at a rate of one every 2 sec in each of five trials. After every trial the participant is to reproduce the memorized words (immediate recall). Twenty minutes after the last trial the participant is asked again to reproduce the set of words (delayed recall). Recorded are the total of correctly reproduced words on five trials, the maximum score in five trials, and the number of correctly reproduced words after 20 min.
The Concept Shifting Task (CST) evaluates behavioral planning and evaluation (18) . It measures one's ability to alternate two psychological concepts during task performance, i.e., number, letter, and number/letter cancellation in correct order. Outcome is the time required to complete each task.
Selective attention and susceptibility to perceptual interference was measured in the Stroop Color Word Test (SCWT; ref. 19) . It consists of three subtasks; color word naming (I), color naming (II), and naming of color words printed in a different color (interference task III).
The Letter Digit Substitution Test (LDST) is a paper-andpencil task, measuring basic information processing speed.
Word Fluency was scored as the total number of unique animal names correctly reproduced in 60 sec (category fluency) (20) . This test reflects the organizational level among clusters of meaningfully related words.
Morbidity Status
The active and total morbidity status at the time of cognitive testing was retrieved from the Registration Network database for each individual. ICPC morbidity classes with a sample prevalence of 13 (=1%) or more were determined to be used in the analyses, including those with potential direct or indirect impact on brain functioning: cardiovascular diseases, obstructive pulmonary disease, atherosclerotic disease, hypertension, endocrine disorders (such as diabetes and thyroid disease), malignancies, hepatic or renal disease, neurological disturbances, and hearing loss (8, 9) . The same procedure was followed for total (active + inactive) morbidity in order to test the potential effect of relevant health events that are only temporarily coded as active, e.g., acute myocardial infarction or brain concussion. The list of all codes that were retained is presented in Table 1 .
Data Reduction
To limit the number of dependent variables and to improve the robustness of the underlying cognitive construct, most of the raw test scores were clustered in three compound performance indices, labeled memory, cognitive flexibility, and sensorimotor speed. For all participants the raw scores were transformed to standardized Z-scores (z = [x -x] ISD). Z-scores from tests that were included in each compound performance index were averaged. Thus, the memory score was derived from the total, maximal, and delayed recall scores of the WLT; the cognitive flexibility score included the C-version of the CST and subtask III of the SCWT; and sensorimotor speed was calculated from the 0, A, and B versions of the CST, and subtask I of the SCWT. Signs of the speed and flexibility scores were inverted to make them reflect above average performance when positive and below average performance when negative. LDST and fluency test outcomes were not included in compound scores, as the performance on these tests is far less dependent on the integrity of one specific cognitive domain.
Several single morbidity codes were uniquely combined in more broad morbidity clusters, including chronic diseases Notes: Only those total morbidity categories are shown that were present in at least 1% of this population: these codes were used in the regression analyses. Categories of active morbidity that were used in the regression analyses (with an associated n > 13) are marked with an asterisk (*). Aggregated morbidity categories are displayed in the second half of the table. Letter/digit codes refer to the respective category in the ICPC coding system.
•n.c.e. = not coded elsewhere. Table 1 ).
Statistical Analysis
Separate linear regression models were fitted for cognitive parameters, adjusting for age, sex, and educational level, by using active or total ICPC morbidity codes that occurred at least in 1 % of all participants (backward elimination procedure). This procedure was repeated for both the active and total aggregated morbidity clusters. All analyses were performed using the SPSS statistical program series (Statistical Package for the Social Sciences, Chicago, IL). Values of p = .01 or less were considered to be statistically significant unless indicated otherwise. Table 1 shows the single and aggregated morbidity categories with an associated prevalence of .01 or higher. It is clear from these data that discrepancies between active and total morbidity status depend in large part on the impact of the disease or complaint on current health and physical functioning. For example, prevalence of active and total presbyacusia (H84) is exactly the same, presumably as the impact of age-associated hearing loss for daily functioning is permanent, but consequences of a disease such as angina pectoris (K74) may disappear after initiation of proper treatment.
RESULTS
All single codes in Table 1 (n = 43) were entered in the analyses for total morbidity, and the codes marked with an asterisk (n = 31) were used in the analysis of active morbidity. Table 2 displays the results of regression analysis of age, sex, educational level, and specific ICPC morbidity codes on cognitive outcome variables. The regression coefficients in the first column demonstrate that age and education are highly associated with all cognitive parameters, and that women out-perform men on memory, cognitive flexibility, and letter-digit copying. Together, the variance in performance explained by age, sex, and educational level ranged between 17% for fluency and 48% for sensorimotor speed.
Final regression models including morbidity codes are displayed in Table 2 for active (column 2) and total morbidity (column 3). All morbidity codes that remained in the models were negatively associated with the performance scores. Most consistently diabetes (T90) was associated with lower performance scores on all cognitive parameters, ranging from -.36 SD in memory to -.52 SD in cognitive flexibility ( Table 2 , column 2: active morbidity), adjusted for the other factors in the model. Other associations between morbidity codes and cognitive parameters were more sporadic, but consistent in the analyses for both active and total morbidity. Chronic bronchitis (R91) remained in the models for sensorimotor speed and cognitive flexibility. Presbyacusia (H84) was present in the model fitted for memory, whereas cholecystitis (D98) accounted for variance in the cognitive flexibility score only when coded as total (column 3). Two other morbidity categories coded as total were present in the model fitted for verbal fluency only: hyperthyroidism (T85) and disturbances in atrial rhythm (K78).
Similar analyses were repeated with the aggregated morbidity codes, as displayed in Table 1 , for active and total morbidity separately. No single significant relation was found between these new variables and cognitive performance levels.
Given the strong association between diabetes and cognitive test performance we did post hoc tests with diabetes as independent variable (coded active), first to evaluate a potential age by diabetes interaction, and second, to differentiate between associations with cognitive function for insulin-and noninsulin-dependent diabetes mellitus (IDDM and NIDDM, respectively). When diabetes and the age by diabetes interaction were entered during the regression procedure, no significant interaction was present on any cognitive parameter on a p < .05 level. This indicates that the association between diabetes and cognitive function is not age dependent. We then repeated the analysis after splitting the diabetes group in insulin users and noninsulin users [n = 15 and n = 35, mean ages 59.6 (SD 14.9) and 69.9 (SD 10.1), respectively, p < .05], based on reported information about medication use by the participant (Table 3) . Except for verbal fluency in the NIDDM group, all remaining cognitive outcome measures were negatively associated with both types of diabetes. Regression coefficients for both types of diabetes were quite comparable in size in all models.
DISCUSSION
Associations between active and total ICPC morbidity and objective neurocognitive test performance were investigated in a healthy adult population sample. Significant negative associations were found between diabetes and all studied cognitive domains, and, more sporadically, between presbyacusia and memory performance and between chronic bronchitis and performance speed (psychomotor speed and cognitive flexibility). Other single associations were only related to total morbidity codes for cholecystitis, hyperthyroidism, and atrial rhythm disturbances. However, related morbidity codes that were aggregated in newly formed clusters did not add to the proportion of explained variance in cognitive measures. Several issues need to be discussed before conclusions can be drawn from these data.
Study participants were stratified for age, sex, and general ability, which are recognized confounding variables in cognitive research. Although demographically this group is not a representative sample of the general population, possible sampling bias due to the stratification procedure was adjusted for by controlling these variables in the regression analyses.
Several specific classes of disease that are theoretically important with respect to brain function (e.g., hepatic cirrhosis) could not be included in the present analyses because their prevalence did not reach the 1% level criterion. Potential significant relations between relatively rare diseases and measures of mental efficiency are unlikely to be identified in a study such as this, because the standard error, and thus the significance, of the regression coefficients describing such a relation strongly depends on the number of cases that are present in the study population. This problem was partly avoided because categories of related morbidity were combined in larger clusters, but only Notes: Shown are the regression coefficients B and its standard error, the associated p-value and the total proportion of variance explained (R 2 ), after step 1 and in the final models. LDST = Letter Digit Substitution Test.
"Age is chronological age. at the cost of a larger disease heterogeneity and lower specificity within the newly defined predictor variables. Two factors that, at least theoretically, can modulate the relation between morbidity and cognitive processes were not included in our models because they could not be reliably assessed: disease duration and intervention (success). First, although it seems reasonable to expect that the impact of disease on cognitive processes is mediated by the duration of exposure to the disease, we consider in most cases the available "date of diagnosis" by the general physician as an inexact indicator of disease duration. In general practice, date of diagnosis is for a large part dependent on patient and physician-related characteristics that are not associated with the actual onset of a disease process: unless identified as a health problem by one or both parties, a disease can remain undetected. Second, adequacy or success of therapeutic intervention is disease-specific and may not be defined in a straightforward sense for purposes such as in this study.
It has been suggested that problems with information processing in patients with a chronic disease are related to restrictions in functional health (3). However, not all participants with a chronic disease in this study experience functional limitations in daily life. An explanation for the absence of a relationship in our data between chronic diseases and cognitive function could be found in the selective participation of relatively fit and healthy participants in this study. This possibility cannot be ruled out entirely, but earlier analyses have shown that participants in MAAS did not differ with the original Registration Network sample with respect to the number of active or total morbidity codes (12), thus making a strong health selection bias due to the inclusion procedure less likely. An intriguing question remains, however, if different aspects of functional health could have accounted for the relation that we found between specific morbidity classes and cognitive function. A post hoc analysis was therefore performed in which available measures of subjective health, IADL (instrumental activities of daily living) and depressive mood, were entered in the regression model together with the significant (active) morbidity variables, but no evidence was found that these functional measures could substitute for morbidity or attenuate the relationship between morbidity and cognitive outcome in any of the final models. The observed associations between ICPC morbidity and cognitive function in part corroborate earlier findings. Diabetic patients have been found to perform worse on tasks of memory and learning, psychomotor speed, and problem solving when compared to healthy controls, possibly due to cerebral changes in blood supply and metabolism, but the affected cognitive domains and the extent of performance deficit vary widely across studies (22) . Elderly NIDDM patients have repeatedly performed worse than controls on verbal and complex cognitive tasks (23) (24) (25) . In this study the domains of verbal memory and information processing speed were also negatively related to diabetes, irrespective of age and insulin dependency. Moreover, comparison of the regression coefficients for IDDM and NIDDM in Table  3 suggests that the strength of association is not substantially different in both types of diabetes. Initially this observation may seem remarkable when disease duration is taken into account. As mentioned earlier, reliable information on disease duration was not available in this group, but generally IDDM is of the early onset type, which would suggest more structural damage and, as a result, more cognitive impairment in IDDM than in NIDDM. One possibility is that progression of cognitive functional loss is limited in the early phase of IDDM in young adulthood to middle age, when the brain has more reserve capacity to compensate for the loss of functional integrity than the brain in older patients with NIDDM (26) , but this explanation remains largely speculative.
Lowered auditory thresholds have been implicated in reduced performance on verbal memory when stimuli are presented acoustically (27) . In this study target words were presented visually to reduce the negative effect of hearing disorders. Still, if older individuals experienced more difficulty in understanding the verbal instruction to the task, the observed negative association between presbyacusia and memory performance may reflect a procedural artifact that needs further consideration.
Interestingly, we did not find relations between single or aggregated cardiovascular morbidity codes and cognitive performance, apart from an isolated single association between word fluency and atrial rhythm disturbances. Other studies have suggested that cardiovascular disease and its risk factors, such as hypertension, are particularly implicated in cognitive decline and dementia (28, 29) . However, cross-sectional studies with a wide age range such as ours may be biased toward underestimating such associations, as vascular disease is the most important cause of death in middle-aged groups, thereby yielding older groups with attenuated vascular risk profiles.
As this study was performed in participants with no overt signs of a cognitive disorder such as dementia, it may be difficult to interpret the clinical relevance of the found associations between several health problems and performance. One way to describe the predictive value of a significant morbidity category for cognitive performance, in the absence of age by morbidity interactions, is to express it in terms of another predictor in the statistical model, in this case the chronological age. For example, one can calculate the average number of years that specific groups of patients are cognitively older, by taking the ratio between the regression coefficients associated with the morbidity code and with age -in years. Thus, active diabetes in our model adds -.462/-.022 = 21 years to the cognitive age on memory function, or -.523/-.027 = 19 years on cognitive flexibility. Even though we cannot make direct infererences on causality, this may seem a rather dramatic notion.
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On a more general level, it seems that prevalent morbidity does not explain a large proportion of individual differences in cognitive abilities. For example, additional variance explained after entry of all active morbidity codes ranged from 1.5% (not significant) to 3.5% (p < .001), for digit copying and word fluency, respectively. This observation may cast some doubt on the contention that physical health is an important mediator of cognitive aging (4, 6, 10, 18, 30) . The prevalence of many health problems correlates strongly with chronological age (Table 1) , albeit age itself still remains the most powerful predictor of cognitive abilities.
Other as yet covert individual characteristics related to age need to be identified to account for this age-associated pool of variance.
In conclusion, the strong negative association between both IDDM and NIDDM and a broad spectrum of cognitive abilities may warrant careful follow-up of these functions by the physician in attendance from the time of diagnosis onward, and should be considered as a possible mediating factor when cognitive dysfunction is found.
